TRIBBLES: A Twist in the Pseudokinase Tail  by Eyers, Patrick A.
Structure
PreviewsTRIBBLES: A Twist in the Pseudokinase TailPatrick A. Eyers1,*
1Department of Biochemistry, Institute of Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK
*Correspondence: patrick.eyers@liverpool.ac.uk
http://dx.doi.org/10.1016/j.str.2015.10.003
TRIB1, a homolog of Drosophila Tribbles, regulates the stability of transcription factors through physical
interaction with the ubiquitin E3 ligase COP1. In this issue of Structure, Murphy et al. (2015) report the first
X-ray analysis of the TRIB1 pseudokinase domain and its C-terminal COP1-binding extension.Pseudokinases are dispersed throughout
the kinomes of all eukaryotic genomes
(Eyers and Murphy, 2013). These some-
what mysterious (and often neglected)
pseudoenzymes have now been shown
to control a glittering array of biological
functions, and their recognition as a
mechanistically diverse family of signaling
proteins has driven their analysis into the
biological mainstream (Reiterer et al.,
2014). Despite lacking one or more of
the amino acid motifs that define canoni-
cal protein kinases, pseudokinases have
been preserved during various phases
of evolution, hinting at unique cellular
roles. This raises fundamental questions
about how structural innovation in the
(pseudo)kinase domain might have influ-
enced functional specification and how
we can exploit such information to under-
stand kinomes, biology, and diseases
(Bailey et al., 2015a).
An interesting example of a pseudoki-
nase is the product of theDrosophila Trib-
bles gene, which regulates border cell
migration in the fly embryo by specifying
the turnover rate of ubiquitinylated target
proteins (Masoner et al., 2013). Vertebrate
TRIBBLES (TRIB) proteins are notable
for divergent pseudocatalytic domains,
in which canonical amino acid motifs are
replaced by unique TRIB signature se-
quences conserved across metazoan
lineages (Bailey et al., 2015b). Key differ-
ences include an acidic ‘‘ELSE’’ motif,
which replaces the canonical ‘‘DFG’’
signature motif found in active kinases,
and a highly unusual aC helix sequence
(Figure 1), thought unlikely to be capable
of forming an ionic interaction with the
invariant basic residue from the b3 strand
(Bailey et al., 2015b). The formation of this
salt bridge is a key effector in the transi-
tion from low to high activity in nearly all
canonical protein kinases (Taylor et al.,
2015), and although its absence supports1974 Structure 23, November 3, 2015 ª2015a kinase-independent signaling function
for TRIB proteins, a lack of structural
information has hampered real mecha-
nistic insight into the TRIB pseudokinase
family.
The second defining feature of TRIB
proteins is a conserved C-terminal patch
of amino acids that acts as a docking
site for the E3 ubiquitin ligase constitutive
photomorphogenesis protein 1 (COP1).
The binding site compromises an ordered
peptide motif (DQLVPD/E), which lies
C-terminal to the TRIB pseudokinase
domain (Figure 1). Studies in flies have
shown that Tribbles can de-stabilize the
fly CDC25 homolog String and the CCAAT
enhancer binding protein (C/EBP) family
of transcription factors, which program
cell-cycle and differentiation phenotypes.
Thus a non-catalytic scaffolding role for
Tribbles in fine-tuning protein stability is
the simplest way of explaining how these
proteins control turnover of specific
cellular ‘‘substrates.’’ However, key ques-
tions remain. For example, why do biolog-
ical and pathological effects of TRIB
proteins rely on an intact pseudokinase
domain (Keeshan et al., 2010), and how
might TRIB proteins bring together
COP1 substrates in a regulated manner,
the latter being of particular importance
given their roles as guardians of cellular
proliferation. To help answer these ques-
tions, researchers have turned to verte-
brate genomes, which contain three
pseudokinase homologs of Tribbles,
termed TRIB1, TRIB2, and TRIB3. A flurry
of recent activity demonstrates that hu-
man TRIBs possess a wide array of
unique and overlapping functions in cells.
These include regulation of cell differenti-
ation and transcription factor stabilization
(e.g., TRIB1 and TRIB2), as well as lipid
metabolism and apoptosis (e.g., TRIB1
and TRIB3). Moreover, common links
to cancer, notably TRIB1 and TRIB2 inElsevier Ltd All rights reservedhuman leukemias (Liang et al., 2013),
make these proteins interesting novel
therapeutic targets, with the unique pseu-
dokinase domain of each TRIB providing
a potentially mouth-watering opportunity
for drug design approaches.
In this issue of Structure, a paper by
Murphy, Mace, and colleagues over-
comes a major barrier to progress in the
TRIB field by revealing the first structures
of a human TRIB pseudokinase domain
and C-terminal extension, which contains
the critical COP1-binding site (Murphy
et al., 2015). The impressive set of
biophysical studies makes fascinating
reading for structural biologists and Trib-
bles aficionados alike. Multiple lines of
evidence demonstrate that TRIB1 pos-
sesses the structural and biochemical
attributes of a catalytically inert pseudoki-
nase, which has evolved non-catalytic
functions through re-deployment of its
pseudokinase N-lobe ‘‘corpse’’ into new
regulatory roles. Highlights of the study
includemolecular details of the potentially
druggable TRIB1 interaction sequence
in the ubiquitylated C/EBPa substrate
and, perhaps most excitingly, details of
an interaction between the C-terminal
COP1-binding region and an epitope in
the N-lobe of the pseudokinase domain
(see below). Together, these data help
explain the unique sensitivity of the (tu-
mor-suppressive) p42 splice variant of
C/EBPa to degradation by TRIB proteins
(Dedhia et al., 2010), since the TRIB1-
binding motif identified between amino
acids 53 and 75 is absent in the shorter
p30 isoform.
Based upon a series of complemen-
tary standard and small-angle X-Ray,
light-scattering, and thermal stability
approaches (Murphy et al., 2014), an
intramolecular TRIB1 pseudokinase do-
main:COP1-binding-site interaction is
proposed and partially validated by the
Figure 1. Comparison of Human TRIB1, TRIB2, and TRIB3 and PKAc a (Pseudo)kinase
Domain Sequences
Critical TRIB1 amino acids discussed by Murphy et al. are labeled blue, and TRIB1 ‘‘R-spine’’’ residues
(pink shading) that co-operate with the highly unusual aC helix to form a binding site for the TRIB C-ter-
minal COP1-bindingmotif (blue shading) are highlighted. In particular, Tyr127, Arg132, Ile135, His140, and
Ile146 in TRIB1 create an unusual platform for docking of key residues conserved in the COP1-binding site
(centered upon the DQLVPD/E motif in the C-terminal flanking region of TRIB1). The absence of structural
information for TRIB2 and TRIB3make aC helix and TRIB ‘‘groove’’ alignments tentative. Red amino acids
are the canonical motifs found in catalytically active PKA (only half of aC helix shown), which also contains
a known cis regulatory element, the FSEF tail motif located at the polypeptide C terminus (shown in
brackets).
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kinase function through in-cis flanking se-
quences is a common regulatory theme
among AGC kinases (Pearce et al., 2010)
and has also been reported for the pseu-
dokinase ROP2 (Kornev and Taylor,
2009). The addition of TRIB1 to this throng
represents an important advance. For
example, the release of the COP1-binding
site from the sequestering pseudokinase
aC helix ‘‘groove’’ (Figure 1) might be
required to trigger targeting of COP1 to
C/EBPa (one of its substrates), which ap-
pears to be the major enzymatic output of
the TRIB1 signalingmodule. Whatever the
precise mechanism turns out to be, the
new picture that emerges is of an ordered
protein assembly orchestrated by a TRIB1
pseudokinase scaffold.
Several other important findings are
revealed in the study. For example, the
TRIB ‘‘ELSE’’ motif and the ‘‘broken’’
TRIB aC helix are confirmed to serve
critical roles that were only previously
hinted at from comparative bioinformatics
(Bailey et al., 2015b; Taylor et al., 2015). In
TRIB1, the ELSE motif can help explain
the detectable absence of ATP binding.
By poisoning the nucleotide-binding site,
Leu226 occludes ATP and prevents active
conformational switching mechanisms
commonly found in ‘‘active’’ kinases.
Perhaps the most fascinating conclusionfrom this study pertains to the TRIB1 aC
helix, whose unusual sequence and
disposition in TRIBs can now be rational-
ized in the context of a new biological
function: a receptor for the critical
COP1-binding motif in the C terminus. A
functional transition of the aC helix from
a critical regulator of catalysis into a
non-catalytic modulator of protein:protein
interaction(s) represents an important
conceptual advance and explains why
TRIB1 best serves its biological role
in the guise of a pseudokinase. One
potentially interesting path for future
work might be to evaluate whether
TRIB2 and/or TRIB3, which are also pre-
dicted to contain ‘‘broken’’ aC-helices
and certainly possess bona fide COP1-
binding sites (Figure 1), employ in cis or
in trans mechanisms of self-recognition
andwhether theymight form homo or het-
erodimeric complexes via these motifs.
Such promiscuity might help explain the
complex phenotypes observed when
different TRIB proteins are manipulated
in cellular studies. In contrast, unique dif-
ferences in sequence within the ‘‘ATP-
binding’’ sites of TRIB1, TRIB2, and
TRIB3 (Figure 1) might permit different
regulatory mechanisms in other regions
of the pseudokinase domain, imparting
switch-like behavior emanating from
distinct sites.Structure 23, November 3, 2015The elegant work of Murphy and col-
leagues (Murphy et al., 2015) is reminis-
cent of earlier publications in Structure in
which the structures of VRK3 and ROP2
pseudokinases were initially reported
(Kornev and Taylor, 2009). Indeed, the
elucidation of key aspects of TRIB1’s reg-
ulatory mechanism will be of importance
to both TRIB and pseudokinase fields
and is likely to have the same impact as
these previous seminal findings did on
the fledgling pseudokinase field in 2009.
Of course, many questions remain. For
example, what was the event that led to
the appearance of TRIB proteins as pseu-
dokinases in the first place? Did the un-
usual aC helix sequence evolve to provide
a competitive or mutually exclusive dock-
ing platform for C/EBPa and the COP1-
binding site in TRIB1? And is such a
mechanism in TRIB pseudokinases a
general link to cellular ubiquitinylation
pathways driven by ubiquitin E3 ligases
distinct from COP1? Finally, a recent
study demonstrates that human TRIB2
possesses weak, metal-independent
ATP binding that can be employed for
the design of small molecule kinase inhib-
itors in vitro (Bailey et al., 2015b). The
discovery of appropriate ligands that
interfere with endogenous TRIBs is there-
fore a key goal for the future (Foulkes
et al., 2015). This might be accomplished
by targeting the unusual (pseudo)catalytic
site of TRIB proteins or, rather appeal-
ingly, by directly interfering with C/EBPa
and/or COP1 interactions motifs, molecu-
lar attributes of which are revealed for the
first time in this study.REFERENCES
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